| Financial Year |
March 31 2023 |
| Monetary Funds |
416,729,471.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
28,234,322.17 |
| Accounts Receivable |
2,826,744.47 |
| Advances to Suppliers |
3,168,143.66 |
| Other Receivables |
730,223.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,179,534.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,593,765.54 |
| Total Current Assets |
459,462,205.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
53,360,500.88 |
| Under-construction Projects |
3,516,124.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
9,782,965.80 |
| Sub-Total of Non-Current Assets |
66,659,591.20 |
| Total Assets |
526,121,797.03 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
33,104,940.75 |
| Accounts Received In Advance |
18,900,702.07 |
| Employee Compensation Payable |
8,212,219.99 |
| Taxes Payable |
1,580,765.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,630,576.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,199,232.25 |
| Sub-Total of Current Liabilities |
74,853,300.56 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,028,056.32 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,028,056.32 |
| Total Liabilities |
87,881,356.88 |
| Paid-In Capital(Or Share Stock) |
798,695,026.00 |
| Capital Surplus |
1,774,130,296.64 |
| Surplus Reserve |
89,143,636.08 |
| LESS:Treasury Stock |
60,821,247.46 |
| Undistributed Profits |
-2,170,362,222.41 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
438,240,440.15 |
| Owner's Equity（Stockholder's Equity） |
438,240,440.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
526,121,797.03 |
